Top 10 Shipping Stocks To Watch Right Now

Even when the market tanks, certain stocks in certain sectors just keep going up. You can find them on the ��ew highs��list. Friday�� capitulation-style dump gives us the opportunity to examine that list for potential buy candidates. Sometimes you can see patterns developing. You might be surprised.

Here are 3 from the new highs list at the close of trading on Friday:

1. GasLog Ltd GasLog Ltd. (NYSE:GLOG) It�� a shipping company headquartered in Monaco. The product they ship is liquefied natural gas. The price/earnings is 26 ��the p/e excluding ��xtraordinary items��is 18. Lot of long-term debt, but they��e been increasing profits for a few years now.  One caution: according to FairOaks Trader, the company has a secondary offering dated 4/26: 4.25 million shares priced at 23.75. Funds will be used to buy 3 new carriers.

2. Gulfport Energy Gulfport Energy (NASDAQ:GPOR) The p/e is approaching steep at 36 now, but what a trend. Gulfport traded at 52 in January ��it�� now at 74. But wait, there�� more: the 2012 low was 16. These ��il and natural gas��outfits have been a theme lately among the stocks hitting new highs.  With GPOR, there�� no dividend, hardly any debt and they��e making money. That 10% short float forces covering as the price keeps heading higher.

Top 5 Restaurant Stocks To Buy Right Now: Montalvo Spirits Inc (TQLA)

Montalvo Spirits Inc., incorporated on November 18, 2010, is a development-stage company. The Company develops, markets and distributes alcoholic beverages with initial offering being the Montalvo Tequila, primarily in the United States. The Company sells its products through a network of spirits distributors, who are licensed to distribute alcoholic beverages throughout the United States. The Company intends to focus on growing the market share of its initial products, the ultra-premium Montalvo line of tequilas, whose expressions include Plata, Reposado, Anejo and Extra-Anejo. The Company owns the Montalvo brand trademark and have exclusive worldwide master distribution rights to the brands.

The Company�� portfolio of alcoholic beverage brands includes additional spirits categories, as well as beer and wine, through additional importation and distribution contracts of existing brands. In addition, the Company may choose to develop new brands or acquire existing companies with their own brand portfolios. The Company�� subsidiary, Casa Montalvo, has an exclusive worldwide distribution agreement with Destilidora Huerta Real, S.A. de C.V., the producers of Montalvo Tequila. Montalvo, an ultra-premium tequila brand, is a handcrafted, formulated tequila produced from blue agave plants from the Lowlands of Jalisco, Mexico. Montalvo is available in four expressions: Plata, Reposado, Anejo and Extra-Anejo.

The Company competes with Diageo PLC, Pernod Ricard S.A., Bacardi Limited, Brown-Forman Corporation, Beam Inc., Remy Cointreau S.A. and Constellation Brands, Inc.

Advisors' Opinion:

• [By CRWE]

  Today, TQLA surged (+10.80%) up +0.042 at $.431 with 1,344,844 shares in play thus far (ref. google finance Delayed: 1:09PM EDT� September 24, 2013).

  Montalvo Spirits, Inc. previously reported they have entered into a sales and marketing agreement with Prestige International Exports, LLC (“Prestige”). Prestige will represent the Montalvo Spirits portfolio brands in certain international markets, as well as provide sales and marketing support for Montalvo Tequila and Broken Heart Gin throughout the state of California, and will assist the Company in attempting to secure distribution in additional markets in the U.S.

Top 10 Shipping Stocks To Watch Right Now: Glu Mobile Inc.(GLUU)

Glu Mobile Inc. designs, markets, and sells mobile games worldwide. It develops original games based on its intellectual property comprising Big Time Gangsta?, Blood & Glory, Bug Village, Contract Killer, Contract Killer: Zombies, Eternity Warriors, Frontline Commando, Gun Bros, Men vs. Machines, Stardom: The A-List, Super K.O. Boxing and Toyshop Adventures. The company also develops games based on licensed intellectual property consisting of Build-a-lot, Call of Duty, Deer Hunter, DJ Hero, Guitar Hero, Family Feud, Family Guy, Lord of the Rings, Paperboy, The Price Is Right, Transformers, Who Wants to Be a Millionaire?, and World Series of Poker. It offers a portfolio of action/adventure and casual games to smartphones and tablet devices users through direct-to-consumer digital storefronts, as well as to feature phone users served by wireless carriers and other distributors. The company was formerly known as Sorrent, Inc. and changed its name to Glu Mobile Inc. in May 20 05. Glu Mobile Inc. was incorporated in 2001 and is headquartered in San Francisco, California.

Advisors' Opinion:

• [By Garrett Cook]

  Technology sector was the top decliner in the market on Thursday. Top losers in the sector included QuickLogic (NASDAQ: QUIK), Glu Mobile (NASDAQ: GLUU), and L-3 Communications Holdings (NYSE: LLL).

• [By kcpl]

  Glu Mobile (GLUU) is off to a solid start in 2014 with impressive results, driven by strong execution and the popularity of its games such as Deer Hunter and Eternity Warriors.

• [By vinaysingh]

  Mobile gaming is a hit-or-miss business and the past has shown that a few consecutive misses can push a company into a downward spiral. Glu Mobile (GLUU) is a prime example of this. The inability to develop chart-topping games took its toll on Glu, but the company has maneuvered a sensational turnaround in the last few months. However, even after the recent uptick, Glu is still a great long-term buy candidate. Let�� take a look at catalysts which will drive Glu Mobile higher in the foreseeable future.

Top 10 Shipping Stocks To Watch Right Now: Bravo Brio Restaurant Group Inc.(BBRG)

Bravo Brio Restaurant Group, Inc. owns and operates Italian restaurant brands in the United States. Its brands include BRAVO! Cucina Italiana, and BRIO Tuscan Grille. The company also operates an American-French bistro restaurant under the brand Bon Vie. As of March 02, 2012, it owned and operated 95 restaurants in 30 states. The company was formerly known as Bravo Development, Inc. and changed its name to Bravo Brio Restaurant Group, Inc. in June 2010. Bravo Brio Restaurant Group, Inc. was incorporated in 1987 and is based in Columbus, Ohio.

Advisors' Opinion:

• [By Shaun Currie, CFA]

  Bravo Brio Restaurant Group (BBRG) presented at a retail/restaurant conference on Tuesday and provided very important information to investors. To give some background, the stock has been an underperformer for two reasons:

• [By CRWE]

  Bravo Brio Restaurant Group, Inc. (Nasdaq:BBRG) owner and operator of the BRAVO! Cucina Italiana (BRAVO!) and BRIO Tuscan Grille (BRIO) restaurant concepts, will host a conference call to discuss third quarter 2012 financial results on Tuesday, October 23, 2012 at 5:00 PM ET.

Top 10 Shipping Stocks To Watch Right Now: Acme United Corp (ACU)

Acme United Corporation, incorporated in 1882, is a worldwide supplier of cutting, measuring and safety products to the school, home, office, hardware and industrial markets. It markets and sells under five main brands - Westcott, Clauss, Camillus, PhysiciansCare and Pac-Kit. The Company has grouped its operations into three segments based on the Company's geographical organization and structure: United States, which includes its Asian operations; Canada and Europe. On February 28, 2011, the Company purchased all of the assets of The Pac-Kit Safety Equipment Company, which is a manufacturer of first aid kits for the industrial, safety, transportation and marine markets. In June 2012, the Company acquired selected assets of The C-Thru Ruler Company. In August 2013, the Company purchased a manufacturing and distribution center in Rocky Mount, North Carolina.

The Company's operations are in the United States, Canada, Europe (located in Germany) and Asia (located in Hong Kong and China). The operations in the United States, Canada and Europe are primarily engaged in product development, marketing, sales, administrative and distribution activities. The operations in Asia consist of sourcing, product development, production planning, quality control and sales activities.

Cutting

Principal products within the cutting device category are scissors, shears, guillotine paper trimmers, rotary paper trimmers, rotary cutters, knives, hobby knives and blades, utility knives, pruners, loppers, saws, manicure products, medical cutting instruments and pencil sharpeners. During the year ended December 31, 2011, products introduced included an expanded line of heavy duty school and office iPoint pencil sharpeners. Other recent product introductions included Westcott TrimAir paper trimmers with patented titanium coating and a blade change system for rotary and personal trimmers, Westcott Ultra Soft Handle scissors with anti-microbial product protection, True Professional sewing shear! s, as well as a line of iPoint pencil sharpeners utilizing the Company's non-stick coating. The Company also added to its KleenEarth family of recycled products by modifying the production process to allow for multi-colored products as opposed to the traditional black. During 2011, Clauss introduced the AirShoc line of titanium coated non stick garden tools.

Measuring

Principal products within the measuring instrument category are rulers, and math tools. During 2011, product introductions included Westcott branded compasses, protractors, rulers and math kits with anti-microbial product protection.

Safety

Principal products within the safety product category are first aid kits, personal protection products and over-the-counter medication refills. The Company markets these products under the PhysiciansCare brand.

The Company competes with Fiskars Corporation, Helix International Ltd. and Johnson and Johnson.

Advisors' Opinion:

• [By Bristol Voss]

  Acme United (NYSE: ACU) is a global supplier of cutting, measuring and safety products to consumer and industrial markets. It has neatly tracked the S&P small-cap index and shown the least volatility of the three stocks. While its $43.7 million market cap is the lowest of the three, its nearly $14 share price is the highest. It has a forward P/E of 9.2, and its dividend yield is the best of the three at 2.3%. In its most recent quarter, Acme posted a 7% increase in net income and a 3% rise in earnings.

Top 10 Shipping Stocks To Watch Right Now: BioCryst Pharmaceuticals Inc.(BCRX)

BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small-molecule pharmaceuticals that block key enzymes involved in infectious diseases, cancer, and inflammatory diseases. It uses structure-based drug design, which incorporates multiple scientific disciplines, including biology, crystallography, medicinal chemistry, and computer to develop new therapeutic candidates. The company has three novel late-stage compounds in development, which include Peramivir, a neuraminidase inhibitor for the potential treatment of influenza; BCX4208, a purine nucleoside phosphorylase (PNP) inhibitor for gout; and Forodesine, a PNP inhibitor for cutaneous T-cell lymphoma (CTCL) and chronic lymphocytic leukemia (CLL). Peramivir is being developed under a contract from the Biomedical Advanced Research and Development Authority within the United States Department of Health and Human Services. Forodesine has been granted orphan drug status by the FDA for thr ee indications, which include T-cell non-Hodgkin?s lymphoma, including CTCL; CLL and related leukemias, including T-cell prolymphocytic leukemia, adult T-cell leukemia, and hairy cell leukemia; and for treatment of B-ALL. The FDA has also granted fast track status to the development of forodesine for the treatment of relapsed or refractory T-cell leukemia, and special protocol assessment from the FDA for forodesine to conduct a pivotal clinical trial in CTCL with an oral formulation. The company announced the initiation of a Phase 2b study of BCX4208 as add-on therapy in gout patients who have not responded to allopurinol therapy alone. BioCryst Pharmaceuticals utilizes crystallography and structure-based drug design to discover additional compounds and to progress others through pre-clinical and early development to address the unmet medical needs of patients and physicians. The company was founded in 1986 and is headquartered in Durham, North Carolina.

Advisors' Opinion:

• [By Matt Egan]

  Other drug makers rallying on the Ebola headlines include BioCryst Pharmaceuticals (BCRX), Inovio Pharmaceuticals (INO) and Sarepta Therapeutics (SRPT).

• [By Monica Gerson]

  BioCryst Pharmaceuticals (NASDAQ: BCRX) shares gained 5.98% to $6.91 in the pre-market session after the company has been awarded contract by the National Institute of Allergy and Infectious Diseases to develop BCX4430 for the treatment of Marburg virus disease.

• [By Roberto Pedone]

  Another under-$10 name in the bio therapeutic space that's starting to move within range of triggering a major breakout trade is BioCryst Pharmaceuticals (BCRX), which designs, optimizes and develops novel drugs that block key enzymes involved in cancer, viral infections and autoimmune diseases. This stock has been on fire so far in 2013, with shares up a whopping 380%.

  If you take a look at the chart for BioCryst Pharmaceuticals, you'll notice that this stock recently formed a double bottom chart pattern at $6.07 to $6.24 a share. Following that bottom, shares of BCRX are now starting to spike higher right off its 50-day moving average of $6.50 a share. That spike is quickly pushing shares of BCRX within range of triggering a major breakout trade.

  Market players should now look for long-biased trades in BCRX if it manages to break out above some near-term overhead resistance levels at $6.88 to $6.89 a share, and then once it takes out more resistance at $7.56 to its 52-week high at $7.80 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 2.51 million shares. If that breakout triggers soon, then BCRX will set up to enter new 52-week-high territory above $7.80, which is bullish technical price action. Some possible upside targets off that breakout are $10 to $12 a share.

  Traders can look to buy BCRX off weakness to anticipate that breakout and simply use a stop that sits right below those key near-term support levels at $6.24 to $6.07 a share. One can also buy BCRX off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

• [By John Udovich]

  While the Twitter IPO has been grabing everyone�� attention, biotech IPOs continue to dominate both biotech and IPO news with Karyopharm Therapeutics Inc (NASDAQ: KPTI) going public yesterday and�Relypsa (NASDAQ: RLYP), TetraLogic Pharmaceuticals (NASDAQ: TLOG), Vital Therapies (NASDAQ: VTL) and Xencor (NASDAQ: XNCR) filing to go public in the near future�(despite the sector producing some�ugly charts�for the month of October) plus�another small cap called TNI BioTech (OTCMKTS: TNIB) has also been producing a steady flow of news:

  Karyopharm Therapeutics Debuts. Yesterday, small cap Karyopharm Therapeutics, which is working on a drug that aids the body�� natural tumor-suppressing proteins,�debuted at the top of�its range to raise $109 million in an upsized�offering of 6.8 million shares at $16 apiece with shares closing at $16.81. It should be noted that Karyopharm Therapeutics��lead drug candidate (Selinexor) is in early-stage clinical trials�and the company lost�lost nearly $12.5 million on revenue of $366,000 during the first six months of this year. Biotech IPOs by Region. On an interesting note, Luke Timmerman, the National Biotech Editor of Xconomy, has written a�good�article tracking biotech or life sciences IPOs by region. By his count, Boston is home to eight of the 45 (18%) of the life sciences IPOs this year (its companies have also�raised the most money - about $770 million)�plus�the New York/northern New Jersey region is also home to�eight. San Diego�came in third with six IPOs followed by San Francisco with five while only five of the 45 biotech IPOs�came from outside the�US (Three from Israel and two from Europe). However, the above figures may change as by his account, there are 15 additional biotech companies in line to go public. More Biotechs Set IPO Terms. The small cap biotech space is about to be joined by a few new additions as a couple of biotechs file to go public�over the past�week or so: Relypsa, which is d

Top 10 Shipping Stocks To Watch Right Now: Humana Inc.(HUM)

Humana Inc. offers various health and supplemental benefit plans in the United States. Its Government segment consists of beneficiaries of government benefit programs; and operates in three lines of businesses, including Medicare, Military, and Medicaid. The Medicare program provides hospital and medical insurance benefits to persons of age 65 and over and some disabled persons under the age of 65. The Military program offers health insurance coverage to the dependents of duty military personnel, and to retired military personnel and their dependents. The Medicaid program is a federal program that is state-operated to facilitate the delivery of health care services primarily to low-income residents. The Commercial segment consists of members enrolled in its medical and specialty products marketed to employer groups and individuals. This segment provides health maintenance organization products that offer prepaid health insurance coverage to its members through a network of independent primary care physicians, specialty physicians, and other health care providers; preferred provider organization products, which are offered primarily to employer groups and individuals; and administrative services only products that are provided to employers who self-insure their employee health plans. It also offers various specialty products, including dental, vision, and other supplemental products, as well as disease management services. As of December 31, 2010, Humana Inc. had approximately 10.2 million members enrolled in medical benefit plans; and approximately 7.1 million members enrolled in specialty products programs. The company markets its products through various channels comprising television, radio, the Internet, telemarketing, and direct mailings. In addition, it has strategic alliances with Wal-Mart Stores, Inc.; State Farm; and United Services Automobile Association to market its products. The company was founded in 1961 and is headquartered in Louisville, Kentucky.

Advisors' Opinion:

• [By Omar Venerio]

  In this article, let's take a look at Humana Inc. (HUM), a $19.29 billion market cap company, which provides a broad range of managed health care services to more than 12 million individuals.

• [By Susan J. Aluise]

  What’s worse: HHS is eying far tougher regulations next year against health plans with narrow provider networks. That means healthcare stocks like Humana (HUM), Cigna (CI), Aetna (AET) and WellPoint (WLP), which have gained more than 50% in the past year, could face headwinds as they try to expand provider networks while keeping premiums low.

• [By Brandy Betz]

  And it was the reversal of a seemingly adverse change behind a health plans rally last week. After an unfavorable government reimbursement decision for Medicare Advantage plans was reversed, shares of Humana (NYSE: HUM  ) and UnitedHealth Group (NYSE: UNH  ) surged to finish up 13% and 9% for the week, respectively.

• [By Sean Williams]

  On one hand, and in all fairness to Obamacare, when was the last time we saw any multibillion-dollar overhaul cost less than initially projected? Then again, these 73% have viable concerns, given that the Centers for Medicare and Medicaid Services, or CMS, reversed a recommendation last month to boost Medicare Advantage reimbursements by 3.3% instead of dropping them by 2.3% as it initially recommended in February. The move, the CMS claims, was made after it recalculated how doctors were being paid. However, it also came on the heels of lobbying attempts by the insurance industry and about 160 lawmakers. If the cost of Obamacare goes well over budget, that'll be great news for Humana (NYSE: HUM  ) �Humana generates 63% of its revenue from Medicare Advantage plans, which are supplemental health plans purchased by seniors to help offset the costs not covered by Medicare. If the government is unable to lower reimbursements to these companies, then Humana may have little to worry about.�

Top 10 Shipping Stocks To Watch Right Now: Brown-Forman Corp (BFB)

Brown-Forman Corporation, incorporated on October 19, 1933, primarily manufactures, bottles, imports, exports, markets, and sells a variety of alcoholic beverage brands. The Company�� principal brands are Jack Daniel�� Tennessee Whiskey, Jack Daniel�� Tennessee Whiskey, Pepe Lopez Tequilas, Jack Daniel�� Single Barrel, Woodford Reserve Bourbons, Jack Daniel�� Ready-to-Drinks, Canadian Mist Blended Canadian Whiskies, Jack Daniel�� Tennessee Honey, Chambord Liqueur, Jack Daniel�� Winter Jack Chambord Vodka, Gentleman Jack, Collingwood Canadian Whisky, Southern Comfort, Early Times Bourbon, Southern Comfort Ready-to-Drinks, Early Times flavored line extensions, Southern Comfort flavored line extensions, Early Times Kentucky Whisky, Finlandia Vodkas, Korbel California Champagnes, Finlandia Ready-to-Drinks, Little Black Dress Vodkas, Antiguo Tequila, Maximus Vodkas, el Jimador Tequilas, Old Forester Bourbon, el Jimador New Mix Ready-to-Drinks, Sonoma-Cutrer Wines, Herradura Tequilas, and Tuaca Liqueur.

The Company�� products are sold in more than 150 countries around the world. The Company�� international markets include Australia, the United Kingdom, Mexico, Germany, Poland, France, Russia, Japan, Turkey, Canada, Spain, Czech Republic, South Africa, Brazil and Italy.

The Company competes with Bacardi Limited, Beam Inc., Davide Campari-Milano S.p.A., Diageo plc, LVMH Moet Hennessy Louis Vuitton S.A., Pernod Ricard S.A., and Remy Cointreau S.A.

Advisors' Opinion:

• [By Maria Armental var popups = dojo.query(".socialByline .popC"); popups.forEach]

  Brown-Forman Corp.(BFB) said its fiscal fourth-quarter earnings jumped 17% as the Jack Daniel’s whiskey maker posted higher sales and wider margins. Earnings beat expectations.

• [By Laura Brodbeck]

  Wednesday

  Earnings Expected From: Christopher & Banks Corporation (NYSE: CBK), Brown Forman Corporation (NYSE: BFB), Express, Inc. (NYSE: EXPR), Avago Technologies (NASDAQ: AVGO) Economic Releases Expected: US nonfarm employment change, US trade balance, Canadian trade balance, US new home sales, US ISM non-manufacturing PMI

  Thursday